Ceapro Inc V.CZO

Chemicals Specialty Chemicals

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.

TSXV:CZO - Post by User

Ceapro Inc > COVID AND THE HEART

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Sep 09, 2023 11:02pm

49 Views

Post# 35628030

RE:RE:COVID AND THE HEART

Gilles, "The Montreal Heart Institute program looking at avenanthramide as a potential anti-inflammatory product and mostly to look at longCOVID patients where they have shown a lot of inflammation symptoms at the cardiovascular level." July 12, 2023 presentation

Colchicine plus aspirin has been tested with positive results treating COVID inflammation. Dr. William Li also believes nitric oxide may be important and avenanthramide increases nitric oxide levels.

Colchicine plus aspirin:

Conclusion: It was evident from CT scan scores that the treatment group has shown significant improvement in the reduction of inflammation and other COVID-19 symptoms as compared to the control group. The fall in Ferritin, Hs-CRP and D-Dimer level after treatment were indicative of improvement in internal inflammatory response of body in COVID-19 disease. As increased troponin levels indicate some degree of heart damage, the fall in troponin levels indicated that test treatment improved heart health in COVID-19 patients.
Effect of colchicine and aspirin given together in patients with moderate COVID-19 - PubMed (nih.gov)

<< Previous

Bullboard Posts

Next >>

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload